^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Y150
i
Other names: Y150
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
YZY Biopharma
Drug class:
CD3 agonist, CD38 inhibitor
Related drugs:
Phase 1
Wuhan YZY Biopharma Co., Ltd.
Recruiting
Last update posted :
08/18/2021
Initiation :
07/08/2021
Primary completion :
07/30/2023
Completion :
12/30/2024
IFNG • IL6 • TNFA • PTPRC • CD69 • IL2 • NCAM1 • IL10 • CD14 • IFNA1
|
Y150
Share
